Table 4 Obstetric and neonatal outcomes in pregnant women with or without active disease at delivery
Outcome parameters | COVID-19 recovered patients | COVID-19 active patients | p-value |
|---|---|---|---|
N = 92 | N = 84 | ||
Mode of delivery | |||
Normal vaginal | 73 (79.35%) | 59 (70.24%) | 0.35 |
Assisted vaginal | 3 (3.26%) | 3 (3.57%) | 0.35 |
Cesarean | 16 (17.39%) | 22 (26.19%) | 0.35 |
Indication for cesarean delivery | |||
Elective | 12 (13.04%) | 13 (15.47%) | 0.48 |
Non-elective | 4 (4.34%) | 9 (10.71%) | 0.48 |
COVID-19-related indications | 0 (0%) | 4 (4.76%) | 0.12 |
Induction of labor | 17 (18.48%) | 17 (20.24%) | 1 |
Gestational age at delivery (weeks) | 39 (30–41) | 39 (28–41) | 0.71 |
Preterm birth (< 37 weeks) | 10 (10.87%) | 7 (8.33%) | 0.61 |
Length of hospitalization (days) | 4 (2–40) | 4 (2–60) | 0.77 |
Antepartum treatment | 2 (2.17%) | 3 (3.57%) | 0.67 |
Postpartum treatment | 10 (10.87%) | 64 (76.19%) | < 0.001 |
Neonatal gender, male | 46 (50%) | 31 (36.9%) | 0.09 |
Birthweight (grams) | 3162 (1250–4206) | 3214 (780–4082) | 0.42 |
Neonatal weight percentile (%) | 53 (3–99) | 56 (4–99) | 0.53 |
Small for gestational age | 8 (8.70%) | 5 (5.95%) | 0.57 |
Large for gestational age | 11 (11.96%) | 10 (11.90%) | 1 |
1-min Apgar < 7 | 1 (1.09%) | 5 (5.95%) | 0.10 |
5-min Apgar < 7 | 1 (1.09%) | 3 (3.57%) | 0.35 |
Cord pH | 7.32 (6.98–7.52) | 7.3 (7.1–7.39) | 0.12 |
pH < 7.2 | 4 (4.35%) | 2 (2.38%) | 1 |
NICU admission | 7 (7.61%) | 8 (9.52%) | 1 |
SARS-CoV-2-positive neonate | 0 (0%) | 6 (7.14%) | < 0.001 |